[HTML][HTML] Immune thrombocytopenia secondary to COVID-19: a systematic review

S Bhattacharjee, M Banerjee - SN comprehensive clinical medicine, 2020 - Springer
Immune thrombocytopenia, often known as immune thrombocytopenic purpura (ITP), has
emerged as an important complication of COVID-19. A systematic review was done to …

[HTML][HTML] Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome

JS Knight, Y Kanthi - Seminars in immunopathology, 2022 - Springer
Antiphospholipid syndrome (APS) is an autoimmune thrombophilia propelled by circulating
antiphospholipid antibodies that herald vascular thrombosis and obstetrical complications …

[HTML][HTML] Thrombophilia, thrombosis and thromboprophylaxis in pregnancy: for what and in whom?

S Middeldorp, C Naue, C Köhler - Hämostaseologie, 2022 - thieme-connect.com
Compared with nonpregnant women, pregnancy carries a four-to fivefold higher risk of
venous thromboembolism (VTE). Despite increasing use of heparin prophylaxis in identified …

[HTML][HTML] Neutrophils—important communicators in systemic lupus erythematosus and antiphospholipid syndrome

L Wirestam, S Arve, P Linge, AA Bengtsson - Frontiers in immunology, 2019 - frontiersin.org
Systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) are two
autoimmune diseases that can occur together or separately. Insights into the pathogenesis …

Efforts to better characterize “antiphospholipid antibody nephropathy” for the 2023 ACR/EULAR antiphospholipid syndrome classification criteria: Renal Pathology …

M Barbhaiya, M Taghavi, S Zuily… - The Journal of …, 2024 - jrheum.org
Objective Antiphospholipid antibody (aPL) nephropathy (-N) can be challenging to
recognize due to a lack of established classification or diagnostic criteria. As part of efforts to …

The role of chloroquine and hydroxychloroquine in immune regulation and diseases

GP Martinez, ME Zabaleta, C Di Giulio… - Current …, 2020 - ingentaconnect.com
Chloroquine (CQ) and hydroxychloroquine (HCQ) are derivatives of the heterocyclic
aromatic compound quinoline. These economical compounds have been used as …

NETs in APS: current knowledge and future perspectives

A Tambralli, K Gockman, JS Knight - Current Rheumatology Reports, 2020 - Springer
Abstract Purpose of Review Antiphospholipid syndrome (APS) is a thrombo-inflammatory
disease that is primarily treated with anticoagulation. Better understanding the inflammatory …

Laboratory diagnostics in thrombophilia

B Linnemann, C Hart - Hämostaseologie, 2019 - thieme-connect.com
A thrombophilic disorder is a hereditary or acquired condition that increases the risk of
thrombosis. The most common hereditary thrombophilias that predispose to venous …

[HTML][HTML] Advances in the pathophysiology of thrombosis in antiphospholipid syndrome: molecular mechanisms and signaling through lipid rafts

A Capozzi, V Manganelli, G Riitano, D Caissutti… - Journal of Clinical …, 2023 - mdpi.com
The pathological features of antiphospholipid syndrome (APS) are related to the activity of
circulating antiphospholipid antibodies (aPLs) associated with vascular thrombosis and …

[HTML][HTML] Molecular mechanisms of “antiphospholipid antibodies” and their paradoxical role in the pathogenesis of “seronegative APS”

R Misasi, A Longo, S Recalchi, D Caissutti… - International Journal of …, 2020 - mdpi.com
Antiphospholipid Syndrome (APS) is an autoimmune disease characterized by arterial
and/or venous thrombosis and/or pregnancy morbidity, associated with circulating …